GEN

Affymetrix: More Than Microarrays

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
technologynetworks

Latest Affymetrix Microarray Offers New Users a Cost-effective and Easy-to-use Alternative for Gene-level Expression Profiling

Affymetrix Inc. has announced the full commercial launch of the GeneChip® Human Gene 1.0 ST Array, the latest addition to its whole-transcript assay-based gene expression product family. The ...
technologynetworks

Affymetrix Participates in Study to Advance MicroArray Technology Towards Widespread Clinical Use

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...
Pharmabiz

Affymetrix's microarray system gets US FDA clearance for gene expression diagnostic testing

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...
The Scientist

Affymetrix Updates Genomes-on-a-Chip

Microarray giant Affymetrix has updated two of its more popular expression sets. With the release of the GeneChip ® Mouse Expression Set 430 and Rat Expression Set 230, the company now provides "the ...
Business Wire

Affymetrix and Ariosa Diagnostics Announce Signing of Multi-Year Supply Agreement in Support of Ariosa’s Non-Invasive Prenatal Test

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...